Stockreport

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and mo [Read more]